Antibiotics-Peptide Conjugates Against Multidrug-resistant Bacterial Pathogens

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Bacterial multi-drug resistance (MDR) poses a significant threat to human and animal health.
• Bacteria develop resistance through mechanisms like efflux pumps, target protection, and genetic mutations.
• Developing novel antibiotics is costly and time-consuming.

Purpose of the Study:

• To review Antibiotics-Peptide Conjugates (APCs) as a strategy against MDR bacterial pathogens.
• To explore APCs for enhancing the efficacy of existing antibiotics.
• To analyze APC strategies and physicochemical properties for improved antibacterial activity.

Main Methods:

• Conjugation of known antibiotics with peptides via linkers to form APCs.
• Investigating APCs for synergistic antibacterial activities.
• Evaluating physicochemical properties of APCs to enhance antibacterial efficacy.

Main Results:

• APCs offer a multifunctional approach to combatting MDR.
• This strategy aims to reduce antibiotic and peptide limitations like poor cell penetration and instability.
• Physicochemical properties data support the potential of APCs in improving antibacterial efficacy.

Conclusions:

• APCs represent a promising strategy to overcome bacterial multi-drug resistance.
• This approach enhances the antibacterial efficacy of existing antibiotics.
• Further research into APCs could lead to novel antimicrobial therapies.